Welcome to Crene Biotechnology!

+86-576-88205808

Product :

CNX-2006

CNX-2006 1375465-09-0
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:CNX-2006 Purity:98% min
CAS NO:1375465-09-0 Solubility:DMSO : ≥ 52 mg/mL (95.32 mM)
Molecular Formula:C26H27F4N7O2 Package:Package according to customer requirements
Molecular Weight:545.532 Storage:Store at -20℃
Quality control
Remarks

CNX-2006 is a potent, mutant-selective EGFR inhibitor with excellent in vitro activity in cells with activating EGFR mutations, as well as in cells harbouring the T790M mutation. CNX-2006 is the prototype for CO-1686, which is currently in a Phase I clinical trial for the treatment of EGFR-mutant lung cancer.

 

 

 

EGFR Inhibitors Related Products:

Erlotinib; Erlotinib hcl; Gefitinib; AG-490; Dacomitinib; WZ4002; Pelitinib; Brigatinib analog; Allitinib; Rociletinib; Varlitinib; Icotinib; WHI-P154; AG-18; Nazartinib

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China